| Stage | CRS | % of rev | TTMI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $798M | 100.00% | $1.2B | 100.00% | TTMI ×1.51 |
| Gross profit | $256M | 32.11% | $292M | 24.24% | CRS +7.9pp |
| Operating income | $196M | 24.61% | $162M | 13.48% | CRS +11.1pp |
| Pre-tax income | $192M | 24.10% | $142M | 11.77% | CRS +12.3pp |
| Net income | $163M | 20.36% | $85M | 7.04% | CRS +13.3pp |
| Stage | CRS | TTMI | Gap · A − B |
|---|---|---|---|
| Revenue | $798M100.00% | $1.2B100.00% | TTMI ×1.51 |
| Gross profit | 32.11%$256M | 24.24%$292M | CRS +7.9pp |
| Operating income | 24.61%$196M | 13.48%$162M | CRS +11.1pp |
| Pre-tax income | 24.10%$192M | 11.77%$142M | CRS +12.3pp |
| Net income |
| 20.36%$163M |
| 7.04%$85M |
| CRS +13.3pp |
No disclosed counterparties: CRS, TTMI.